Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2017 Publisher: Merck Sharp & Dohme Limited, Hertford Road, Hoddesdon, Hertfordshire, EN119BU, UK
Pregnyl 5000 I.U. powder for solution for injection.
| Pharmaceutical Form |
|---|
|
Powder for solution for injection. The powder is a white, dry powder or cake. |
Pregnyl consists of a freeze-dried powder for injection. The active ingredient [human chorionic gonadotrophin (hCG)] which is obtained from the urine of pregnant women, has luteinizing hormone (LH) activity.
An ampoule contains 5000 I.U. hCG.
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Chorionic gonadotrophin (human) |
Human chorionic gonadotrophin stimulates the steroidogenesis in the gonads by virtue of a biological effect similar to that of LH (Luteinizing hormone, which is the same as interstitial cell stimulating hormone). |
| List of Excipients |
|---|
|
Powder for injection contains: Carmellose sodium |
2ml ampoule containing freeze-dried powder with 1ml ampoule of solvent (sodium chloride 9mg/ml). Pregnyl is available in packs of 1, 3 or 10 ampoules of powder and solvent.
Not all pack sizes may be marketed.
In correspondence please quote batch number.
Merck Sharp & Dohme Limited, Hertford Road, Hoddesdon, Hertfordshire, EN119BU, UK
PL 00025/0556
24 February 1991/25 March 2003
| Drug | Countries | |
|---|---|---|
| PREGNYL | Austria, Australia, Canada, Germany, Estonia, Finland, Lithuania, Netherlands, New Zealand, Poland, Singapore |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
